Shree Ganesh Remedies bags Jaiswal Pharmachem plot in Gujarat

Image
Capital Market
Last Updated : Mar 12 2022 | 4:31 PM IST

Shree Ganesh Remedies made a winning bid of Rs 26 crore for Jaiswal Pharmachem's 20,100 sq. m. plot in Ankleshwar, Gujarat.

The company is declared as the highest bidder with Rs 26 crore bid, for the e-auction of assets of Jaiswal Pharmachem, i.e., Plot No 6002 and 6003, GIDC Estate, Ankleshwar (land area approx. 20,100 sq. m.) (Gujarat).

The net profit of Shree Ganesh Remedies surged 51.62% to Rs 4.20 crore in the quarter ended December 2021 as against Rs 2.77 crore during the previous quarter ended December 2020. Net sales jumped 59.35% to Rs 21.13 crore in the quarter ended December 2021 as against Rs 13.26 crore during the previous quarter ended December 2020.

Shares of Shree Ganesh Remedies rose 1.28% to close at Rs 281.75 on BSE on Friday, 11 March 2022.

Shree Ganesh Remedies is an Indian pharmaceuticals company. Its core activities consist of manufacturing & export of pharmaceutical intermediates & fine chemicals and research & development.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 12 2022 | 1:30 PM IST

Next Story